Scout | Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)

This grant opportunity supports collaborative research between experienced investigators in low- and middle-income countries (LMICs) and the United States, focusing on Alzheimer's disease and related dementias like frontotemporal dementia and Lewy body dementia. The research aims to build sustainable capacity in neuroscience and develop strategies for prevention and mitigation of these disease…

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Aging

Award

Award Ceiling: $400,000

Funding Amount: $400,000

Dates

Opportunity Released: September 6, 2024

Open for Submission: September 6, 2024

Submission Deadline: February 14, 2025

Application Window Closes: February 14, 2025

Keywords

Alzheimer's disease

dementia research

low- and middle-income countries

neuroscience capacity building

collaborative research

frontotemporal dementia

vascular cognitive impairment

Lewy body dementia

international collaboration

prevention strategies.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers